The Journal of General and Applied Microbiology
Online ISSN : 1349-8037
Print ISSN : 0022-1260
ISSN-L : 0022-1260
Full Papers
In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2
Jirayut EuanorasetrBungonsiri IntraNutthanit ThunmrongsiriJitra LimthongkulSukathida UbolAtchareeya AnuegoonpipatTakeshi KurosuKazuyoshi IkutaTakuya NihiraWatanalai Panbangred
Author information
JOURNALS FREE ACCESS

2019 Volume 65 Issue 4 Pages 197-203

Details
Abstract

Spirotetronate compounds are polyketide secondary metabolites with diverse biological functions, such as antibacterial, antitumor and antiviral activities. Three pure spirotetronate compounds (2EPS-A, -B, -C) isolated from Actinomadura strain 2EPS showed inhibitory activity against dengue virus serotype 2 (DENV-2). 2EPS-A, -B and -C demonstrated the LC50 values of 11.6, 27.5 and 12.0 μg/ml, respectively, in a test of cytotoxicity to Vero cells. The least cytotoxic, 2EPS-B, was further analyzed for its impact on viral propagation in a cell-based replication assay. At a concentration of 6.25 μg/ml, it could reduce the DENV-2 infection in Vero cells by about 94% when cells infected with DENV-2 were exposed to 2EPS-B, whereas direct treatment of DENV-2 with 2EPS-B at the same concentration prior to subsequent infection to Vero cell yielded no inhibition. 2EPS-A, -B an -C showed strong DENV-2 NS2B-NS3 protease inhibition in an in vitro assay, with IC50 values of 1.94 ± 0.18, 1.47 ± 0.15 and 2.51 ± 0.21 μg/ml, respectively. Therefore, the spirotetronate compounds appear to prevent viral replication and viral assembly by inhibition of the viral protease.

Information related to the author
© 2019, Applied Microbiology, Molecular and Cellular Biosciences Research Foundation
Previous article Next article
feedback
Top